Immunohistochemistry Market by Product, Disease Type, End-user, Application - Global Forecast 2025-2030- Product Image

Sale

Immunohistochemistry Market by Product, Disease Type, End-user, Application - Global Forecast 2025-2030

Report
198 Pages
October 2024
Region: Global
360iResearch™
ID: 5137198

UP TO €695EUR$697USD£573GBP OFF until Dec 31^st 2024

The Immunohistochemistry Market grew from USD 2.98 billion in 2023 to USD 3.15 billion in 2024. It is expected to continue growing at a CAGR of 5.88%, reaching USD 4.46 billion by 2030.

Immunohistochemistry (IHC) is a critical technique used in laboratories to visualize the presence and localization of specific antigens in tissue sections by employing antibodies. The necessity of IHC arises from its pivotal role in diagnosing diseases like cancer, guiding treatment plans, and conducting research on pathological processes. It is widely applied in various fields, such as oncology, pathology, and developmental biology, with its end-use scope extending to hospitals, diagnostic laboratories, academic institutes, and research centers. The IHC market is expanding due to factors like the increasing prevalence of chronic diseases, advancements in diagnostic technologies, and an aging population demanding better healthcare solutions. Recent opportunities include the integration of IHC with digital pathology and AI, allowing for enhanced diagnostic accuracy and efficiency. Companies can capitalize on these breakthroughs by investing in product innovation and collaboration with AI technology firms. However, the market faces challenges like high costs associated with IHC processes, a need for highly skilled personnel, and potential technical limitations in detecting certain antigens. To mitigate these challenges, firms could explore automating IHC procedures and enhancing reagent specificity. Innovation efforts should focus on enhancing multiplexing capabilities, which allow for the simultaneous detection of multiple biomarkers, and developing user-friendly digital platforms for data analysis and sharing. The market's competitive nature demands a focus on reliability, accuracy, and cost-effectiveness of offerings. As IHC continues to evolve, leveraging personalized medicine trends and investing in robust R&D are strategies poised to yield growth. Fostering partnerships with academic institutions for clinical trials and technology development can provide an edge. Overall, while the IHC market holds significant promise, navigating its complexities requires strategic planning and a concerted emphasis on technological, operational, and educational advancements.

Understanding Market Dynamics in the Immunohistochemistry Market

The Immunohistochemistry Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Extensive prevalence of chronic diseases such as cancer and autoimmune diseases among population
- Increasing government funding and initiatives to improve cancer diagnostics
- Growing demand for personalized/customized medicine
Market Restraints
- Issues related to the collection, storage, and use of biopsy samples
Market Opportunities
- Introduction of automated and semi-automated immunohistochemistry systems
- Collaborations between diagnostic companies, research institutes, and healthcare
Market Challenges
- Concerns pertinent to product failure and shortage of skilled professionals

Exploring Porter’s Five Forces for the Immunohistochemistry Market

Porter’s Five Forces framework further strengthens the insights of the Immunohistochemistry Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Immunohistochemistry Market

External macro-environmental factors deeply influence the performance of the Immunohistochemistry Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Immunohistochemistry Market

The Immunohistochemistry Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Immunohistochemistry Market

The Immunohistochemistry Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Immunohistochemistry Market

The Immunohistochemistry Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunohistochemistry Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies Inc., Becton, Dickinson & Company, Bio SB, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Biocare Medical LLC, Biogenex Laboratories, CANDOR Bioscience GmbH, Cell Signaling Technology, Inc., Danaher Corporation, Diagnostic BioSystems Inc., Eagle Biosciences, Inc., Elabscience Biotechnology Inc., F. Hoffman-La Roche AG, Genemed Biotechnologies, Inc. by Sakura Finetek Japan Co., Ltd, Histo-Line Laboratories, Lunaphore Technologies SA, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, PerkinElmer Inc., Rockland Immunochemicals, Inc., Takara Bio, Inc, and Thermofisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Immunohistochemistry Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Antibodies
  - Primary Antibodies
  - Secondary Antibodies
- Equipment
  - Slide Scanners
  - Slide Staining Systems
  - Tissue Microarrays
  - Tissue Processing Systems
- Kits
- Reagents
  - Blocking Sera & Reagents
  - Chromogenic Substrates
  - Diluents
  - Fixation Reagents
  - Histological Stains
  - Organic Solvents
  - Proteolytic Enzymes
  - Stabilizers
Disease Type
- Autoimmune Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes Mellitus
- Infectious Diseases
- Nephrological Diseases
End-user
- Academic & Research Institutes
- CROs
- Forensic Labs
- Hospitals & Diagnostic Laboratories
- Pharma & Biopharma Companies
Application
- Diagnostics
- Drug Testing
- Forensic

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Extensive prevalence of chronic diseases such as cancer and autoimmune diseases among population
5.1.1.2. Increasing government funding and initiatives to improve cancer diagnostics
5.1.1.3. Growing demand for personalized/customized medicine
5.1.2. Restraints
5.1.2.1. Issues related to the collection, storage, and use of biopsy samples
5.1.3. Opportunities
5.1.3.1. Introduction of automated and semi-automated immunohistochemistry systems
5.1.3.2. Collaborations between diagnostic companies, research institutes, and healthcare
5.1.4. Challenges
5.1.4.1. Concerns pertinent to product failure and shortage of skilled professionals
5.2. Market Segmentation Analysis
5.2.1. Application: Increasing usage of immunohistochemistry in forensic science for the identification of tissue samples and body fluids at crime scenes
5.2.2. Product: Increasing demand for secondary antibodies for accurate and reliable results
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Immunohistochemistry Market, by Product

6.1. Introduction
6.2. Antibodies
6.2.1. Primary Antibodies
6.2.2. Secondary Antibodies
6.3. Equipment
6.3.1. Slide Scanners
6.3.2. Slide Staining Systems
6.3.3. Tissue Microarrays
6.3.4. Tissue Processing Systems
6.4. Kits
6.5. Reagents
6.5.1. Blocking Sera & Reagents
6.5.2. Chromogenic Substrates
6.5.3. Diluents
6.5.4. Fixation Reagents
6.5.5. Histological Stains
6.5.6. Organic Solvents
6.5.7. Proteolytic Enzymes
6.5.8. Stabilizers

7. Immunohistochemistry Market, by Disease Type

7.1. Introduction
7.2. Autoimmune Diseases
7.3. Cancer
7.4. Cardiovascular Diseases
7.5. Diabetes Mellitus
7.6. Infectious Diseases
7.7. Nephrological Diseases

8. Immunohistochemistry Market, by End-user

8.1. Introduction
8.2. Academic & Research Institutes
8.3. CROs
8.4. Forensic Labs
8.5. Hospitals & Diagnostic Laboratories
8.6. Pharma & Biopharma Companies

9. Immunohistochemistry Market, by Application

9.1. Introduction
9.2. Diagnostics
9.3. Drug Testing
9.4. Forensic

10. Americas Immunohistochemistry Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Immunohistochemistry Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Immunohistochemistry Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Tempus launches advanced HER2 and FOLR1 IHC tests to enhance precision medicine and targeted cancer therapies
13.3.2. Roche secures CE Mark for VENTANA HER2 (4B5) test, enhancing treatment options for HER2-low metastatic breast cancer with ENHERTU
13.3.3. Cell signaling technology introduces SignalStar Multiplex IHC technology
13.3.4. Danaher Corporation to acquire UK-based Abcam to enhance drug discovery and disease mapping capabilities
13.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. IMMUNOHISTOCHEMISTRY MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOHISTOCHEMISTRY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. IMMUNOHISTOCHEMISTRY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. IMMUNOHISTOCHEMISTRY MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. IMMUNOHISTOCHEMISTRY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOHISTOCHEMISTRY MARKET DYNAMICS
TABLE 7. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 70. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 71. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 72. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 78. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 107. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 108. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 109. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 110. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 114. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 115. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 116. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 117. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 128. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 129. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 130. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 131. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 149. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 150. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 152. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 156. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 157. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 163. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 164. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 165. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 166. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 170. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 171. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 172. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 173. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 177. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 178. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 179. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 180. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 190. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 192. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 193. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 194. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 195. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 199. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 200. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 201. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 202. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 206. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 207. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 208. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 209. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 212. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 213. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 214. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 215. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 216. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 220. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 221. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 222. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 223. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 234. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 235. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 236. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 237. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 255. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 256. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 257. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 258. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 262. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 263. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 264. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 265. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 268. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 269. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 270. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 271. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 272. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 296. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 297. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 298. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 299. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 300. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 301. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 307. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 308. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 310. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 311. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 317. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 318. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 319. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 320. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 321. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 322. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 332. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
TABLE 334. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 335. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 336. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. IMMUNOHISTOCHEMISTRY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 338. IMMUNOHISTOCHEMISTRY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Immunohistochemistry market, which are profiled in this report, include:

Agilent Technologies Inc.
Becton, Dickinson & Company
Bio SB
Bio-Rad Laboratories Inc.
Bio-Techne Corporation
Biocare Medical LLC
Biogenex Laboratories
CANDOR Bioscience GmbH
Cell Signaling Technology, Inc.
Danaher Corporation
Diagnostic BioSystems Inc.
Eagle Biosciences, Inc.
Elabscience Biotechnology Inc.
F. Hoffman-La Roche AG
Genemed Biotechnologies, Inc. by Sakura Finetek Japan Co., Ltd
Histo-Line Laboratories
Lunaphore Technologies SA
Merck KGaA
Miltenyi Biotec B.V. & Co. KG
PerkinElmer Inc.
Rockland Immunochemicals, Inc.
Takara Bio, Inc
Thermofisher Scientific, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	198
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.15 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.46 Billion
Compound Annual Growth Rate	5.8%
Regions Covered	Global
No. of Companies Mentioned	24

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3535EUR$3,545USD£2,916GBP €3928EUR$3,939USD£3,239GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6255EUR$6,272USD£5,158GBP €6950EUR$6,969USD£5,731GBP

Understanding Market Dynamics in the Immunohistochemistry Market

Exploring Porter’s Five Forces for the Immunohistochemistry Market

Applying PESTLE Analysis to the Immunohistochemistry Market

Analyzing Market Share in the Immunohistochemistry Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Immunohistochemistry Market

Strategic Recommendations for Success in the Immunohistochemistry Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Immunohistochemistry (IHC) - Market Insights, Competitive Landscape, and Market Forecast- 2030

Immunohistochemistry (IHC) Market by Product (Antibodies (Type, Clonality), Reagents, Equipment, Kits, Software), Application (Diagnostics (Cancer, Infectious, Autoimmune, Neurological), Research (Drug Development), Forensic) - Global Forecast to 2029

Immunohistochemistry (IHC) Global Market Report 2024

Immunohistochemistry Market Report by Product, Application, End Use, and Region 2024-2032

Immunohistochemistry - Global Strategic Business Report